These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16432951)

  • 21. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M; Nordestgaard BG; Jensen GB; Tybjaerg-Hansen A
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):661-70. PubMed ID: 17170368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations.
    Wang W; Lopaschuk GD
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1123-34. PubMed ID: 18035928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis.
    Troelsen LN; Garred P; Madsen HO; Jacobsen S
    Arthritis Rheum; 2007 Jan; 56(1):21-9. PubMed ID: 17195187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischemic heart disease in women.
    Pepine CJ
    J Am Coll Cardiol; 2006 Feb; 47(3 Suppl):S1-3. PubMed ID: 16458166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of Fas in the progression of ischemic heart failure: prohypertrophy or proapoptosis.
    Feng QZ; Zhao YS; Abdelwahid E
    Coron Artery Dis; 2008 Nov; 19(7):527-34. PubMed ID: 18923250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease.
    Manolakis A; Kapsoritakis AN; Potamianos SP
    Helicobacter; 2007 Aug; 12(4):287-97. PubMed ID: 17669100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bibliography. Current world literature. Valvular heart disease.
    Curr Opin Cardiol; 2006 Mar; 21(2):144-51. PubMed ID: 16596745
    [No Abstract]   [Full Text] [Related]  

  • 28. Bibliography. Current world literature. Valvular heart disease.
    Curr Opin Cardiol; 2007 Mar; 22(2):152-60. PubMed ID: 17415940
    [No Abstract]   [Full Text] [Related]  

  • 29. Epsilon protein kinase C as a potential therapeutic target for the ischemic heart.
    Inagaki K; Churchill E; Mochly-Rosen D
    Cardiovasc Res; 2006 May; 70(2):222-30. PubMed ID: 16635641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bibliography. Current world literature. Valvular heart disease.
    Curr Opin Cardiol; 2008 Mar; 23(2):155-7. PubMed ID: 18376509
    [No Abstract]   [Full Text] [Related]  

  • 31. AMP-activated protein kinase control of energy metabolism in the ischemic heart.
    Lopaschuk GD
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S29-35. PubMed ID: 18719595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurogenic hypothesis of cardiac ischemic pain.
    Wang Y; Zeng XL; Gao RR; Wang XM; Wang XT; Zheng GQ
    Med Hypotheses; 2009 Apr; 72(4):402-4. PubMed ID: 19131176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of norepinephrine in myocardial ischemia and ischemic preconditioning].
    Naumenko SE; Gilinskiĭ MA
    Usp Fiziol Nauk; 2009; 40(2):26-39. PubMed ID: 19505021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial.
    Zwisler AD; Soja AM; Rasmussen S; Frederiksen M; Abedini S; Appel J; Rasmussen H; Gluud C; Iversen L; Sigurd B; Madsen M; Fischer-Hansen J;
    Am Heart J; 2008 Jun; 155(6):1106-13. PubMed ID: 18513526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceived stress and risk of ischemic heart disease: causation or bias?
    Nielsen NR; Kristensen TS; Prescott E; Larsen KS; Schnohr P; Grønbaek M
    Epidemiology; 2006 Jul; 17(4):391-7. PubMed ID: 16755264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ivabradin (coraxan). One more new approach to fighting myocardial ischemia in patients with ischemic heart disease].
    Eliseev OM
    Ter Arkh; 2006; 78(9):78-86. PubMed ID: 17076230
    [No Abstract]   [Full Text] [Related]  

  • 38. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-based therapy for ischemic heart disease: a clinical update.
    Herrmann JL; Abarbanell AM; Weil BR; Wang Y; Wang M; Tan J; Meldrum DR
    Ann Thorac Surg; 2009 Nov; 88(5):1714-22. PubMed ID: 19853156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of electrocardiographic ST-T changes during acute ischemic stroke in patients without known ischemic heart disease.
    Jensen JK; Bak S; Flemming Høilund-Carlsen P; Mickley H
    Int J Cardiol; 2008 Aug; 128(1):137-8. PubMed ID: 17683810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.